Acurx Pharmaceuticals, Inc.
SEC CIK 1736243 · ACXP · last insider filing 2026-04-22
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Deluccia Robert J | Director | filed 2021 - 2026 |
| Harrison Thomas L | Director | filed 2021 - 2026 |
| Luci David P | Director · President and CEO | filed 2021 - 2026 |
| Scodari Joseph C | Director | filed 2021 - 2026 |
| Dean Jack H | Director | filed 2021 - 2026 |
| Sailer Carl | Director | filed 2021 - 2026 |
| Donohue James J. | Director | filed 2021 - 2026 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Shawah Robert G. | Chief Financial Officer | filed 2021 - 2026 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.